Bristol Myers Squibb plans to discuss marketing applications with both the FDA and EMA.

The entities involved

• FDA →
  • The FDA provided funding for the new vessel M/V Captain Dinsmore in May 2026.05:39
  • Cloudbreak Pharma Inc. intends to meet with the FDA to review its study findings.Thu 04:41
• EMA →

  Japanese vocalist of the group DUSTCELL

  Nothing else this week.

• Bristol-Myers Squibb →

  American pharmaceutical company

  • Gardiner Harris's investigative reporting led to fraud fines against Bristol-Myers Squibb and a book dissecting Johnson & Johnson scandals.Tue 01:35
  • Dean Hakanson led U.S. Medical Affairs for the remdesivir launch and served in senior leadership positions at major pharmaceutical companies.Mon 17:32

Related events

• Omeros Corporation's drug received FDA approval and is currently undergoing review by the European Medicines Agency.Jun 26
• Bristol-Myers Squibb and AbbVie secured regulatory approval for a therapy in the US.Oct 21
• FDA approval is the goal for product candidates from Daré Bioscience, Inc.Jun 7
• Eli Lilly and Company plans to submit a drug candidate to the FDA for review and approval.Aug 5
• FDA policy proposal affects the operations of AI, Inc.Oct 16